KS100（Cat No.:I043678）is a small molecule inhibitor designed to target specific proteins involved in cancer cell growth and survival. It works by disrupting key signaling pathways that regulate tumor proliferation and resistance to treatment. In preclinical studies, KS100 has shown promise in inhibiting the growth of various cancer cell types, particularly by interfering with critical processes like cell cycle regulation and apoptosis. With its high potency and selectivity, KS100 is a valuable tool in cancer research, offering potential for the development of targeted therapies aimed at overcoming cancer resistance and improving treatment outcomes.